Finance

Lists
ALPMY:OTCMKTS
Astellas Pharma ADR Representing 1 Ord Shs
$ 14.32
-0.83%
(-0.12) 1D
10-р сарын 2, 16:00:00 (GMT-4)  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for ALPMY...
Open
$ 14.26
High
$ 14.38
Low
$ 14.25
Mkt. cap
4.06ИН
Avg. vol.
100.83 мян
Volume
93.00 мян
52-wk high
$ 17.35
52-wk low
$ 10.03
Beta
0.13
Shares outstanding
1.81 тэрбум
No. of employees
14 мян
Open
$ 14.26
High
$ 14.38
Low
$ 14.25
Mkt. cap
4.06ИН
Avg. vol.
100.83 мян
Volume
93.00 мян
52-wk high
$ 17.35
52-wk low
$ 10.03
Beta
0.13
Shares outstanding
1.81 тэрбум
No. of employees
14 мян
News stories
From web sources and news partners
Profile
Astellas Pharma Inc. is a Japanese multinational pharmaceutical company, formed on 1 April 2005 from the merger of Yamanouchi Pharmaceutical Co., Ltd. and Fujisawa Pharmaceutical Co., Ltd. Astellas is a member of the Mitsubishi UFJ Financial Group keiretsu. Wikipedia
About Astellas Pharma ADR Representing 1 Ord Shs
CEONaoki Okamura
Employees14.1 мян
Founded2005 оны 4-р сарын 1
HeadquartersChuo City, Токио, Япон
SectorPharmaceutical industry
Previous reportsAll values in JPY
Loading Previous Earnings...
Revenue
Net income
All values in JPY
2025 оны 9-р сар
2025 оны 12-р сар
2026 оны 3-р сар
2026 оны 6-р сар
Revenue
524.32Т
554.57Т
537.92Т
640.91Т
Cost of goods sold
105.53Т
104.03Т
93.67 тэрбум
122.70Т
Cost of revenue
105.53Т
104.03Т
93.67 тэрбум
122.70Т
Research and development expenses
71.59 тэрбум
85.77 тэрбум
95.94 тэрбум
81.73 тэрбум
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
206.84Т
228.24Т
234.70Т
215.07Т
Operating expense
325.88Т
358.98Т
336.48Т
332.86Т
Total operating expenses
431.41Т
463.01Т
430.14Т
455.56Т
Operating income
92.91 тэрбум
91.55 тэрбум
107.78Т
185.35Т
Other non operating income
-
1.50 сая
-241.00 сая
1.00 сая
EBT including unusual items
104.19Т
90.99 тэрбум
48.02 тэрбум
186.51Т
EBT excluding unusual items
92.38 тэрбум
90.82 тэрбум
113.57Т
186.51Т
Income tax expense
24.98 тэрбум
19.02 тэрбум
4.41 тэрбум
44.76 тэрбум
Effective tax rate
23.97%
20.90%
9.18%
24.00%
Other operating expenses
14.73 тэрбум
9.72 тэрбум
-29.93 тэрбум
388.00 сая
Net income
79.21 тэрбум
71.95 тэрбум
43.52 тэрбум
141.83Т
Net profit margin
15.11%
12.97%
8.09%
22.13%
Earnings per share
-
-
-
-
Interest and investment income
2.15 тэрбум
2.10 тэрбум
1.29 тэрбум
5.13 тэрбум
Interest expense
-2.69 тэрбум
-2.74 тэрбум
-
-3.12 тэрбум
Net interest expenses
-541.00 сая
-637.00 сая
1.29 тэрбум
2.01 тэрбум
Depreciation and amortization charges
-32.77 тэрбум
-
35.76 тэрбум
-
EBITDA
140.20Т
141.30Т
158.14Т
235.24Т
Gain or loss from assets sale
16.40 тэрбум
-
31.51 тэрбум
-
AI content may include mistakes. Learn more
Google аппс